Post-traumatic stress disorder is a body condition that occurs when a stressful event happens. It is the past period that does not mean that the person stays in a dangerous situation, but it shows the triggers that appear in human cognition (Mitchell et al., 2021). The neuroscience of traumas is widely studied in the medical sphere and more new treatments appear to fight against PTSD. For instance, Mitchell et al. (2021) have conducted a study with the help of Van der Kolk which showed that a small consumption of MDMA can help to cope with the issue. Patients with post-traumatic stress disorder were given three doses of MDMA and a placebo to avoid psychosomatic results. The results showed that the effect of the drug is different for diverse genders and ages, but the general outcome showed that the use of MDMA can help to treat PTSD in a short period of time.
The use of this type of treatment is rarely supported by some parties. The biblical integration denies the effect of MDMA in the treatments as in some countries and regions of the USA it is banned (Sessa, 2017). Nevertheless, professionals in the healthcare sector accurately check the health of the patient before suggesting consuming MDMA to decrease the effect of PTSD. People become more extroverted and their minds dive into euphoria making their social integration more active (Sessa, 2017). Consequently, the effect of the drug on the neurological system and general condition help expert guide patients and help them to cope with the disturbing problem. This technique is considered to be one of the most effective as the main symptom of PTSD is difficulty with building social contacts and MDMA help to overcome this issue. Consequently, it should not be underestimated by medical workers and suggested to patients with other treatment types like yoga or EMDR.
References
Mitchell, J. M., Bogenschutz, M., and Lilienstein, A. (2021). MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27, 1025-1033.
Sessa, B. (2017). MDMA and PTSD treatment: “PTSD: From novel pathophysiology in innovative therapeutics.” Neuroscience Letters, 649, 176-180. Web.